Home

Charles J Dockendorff

CIK 1400563 · EVP & Chief Financial Officer · last filed 2026-04-09

Charles J Dockendorff is an EVP & Chief Financial Officer who has filed 124 SEC Form 4 insider transactions across 5 companies since 2007. Across all open-market trades the lifetime net is −$42.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $24.7M across reported positions. 17 SEC filings were submitted jointly with BOSTON SCIENTIFIC CORP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$24.68M

Companies

5

Total Filings

124

Lifetime Open-Market Net

-$42.19M

Filer Profile

Reported Address
HOLOGIC, INC.
250 CAMPUS DRIVE
MARLBOROUGH, MA 01752
Related Filers
BOSTON SCIENTIFIC CORP — 17 joint filings, latest 2024-05-13
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KEYS Director 55,213 $362.98 $20.04M -$103.3K 18 2026-03-24
HOLOGIC INC (HOLX) Delisted Director 21,996 $76.01 $1.67M -$760.5K 12 2026-03-02
HAE Director 25,041 $105.40 $2.64M -$2.53M 13 2025-07-25
BSX Director 45,523 $43.90 $2.00M -$658.8K 14 2024-05-13
Covidien plc (COV) Delisted EVP & Chief Financial Officer 136,031 — — -$38.14M 60 2014-12-04

Recent Filings

124 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-04-09 — Disp (D) −21,996 $0
2026-03-24 KEYS Grant (A) +870 $0 EDGAR
2026-03-02 HOLOGIC INC (HOLX) Delisted Grant (A) +3,190 $0 EDGAR
2025-07-25 HAE Grant (A) +2,693 $0 EDGAR
2025-03-25 KEYS Grant (A) +1,589 $0 EDGAR
2025-02-28 HOLOGIC INC (HOLX) Delisted Grant (A) +1,864 $0 EDGAR
2024-07-26 HAE Grant (A) +2,207 $0 EDGAR
2024-05-13 BSX Grant (A) +2,901 $0 EDGAR
2024-05-08 BSX Sell (S) −3,946 -$286.9K EDGAR
2024-05-07 BSX Notice (144) −3,946 -$286.9K EDGAR
Showing 1–10 of 124
Page 1 of 13
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.